<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>05132nam a22006255i 4500</leader>
  <controlfield tag="001">978-3-031-65827-3</controlfield>
  <controlfield tag="003">DE-He213</controlfield>
  <controlfield tag="005">20251030112639.0</controlfield>
  <controlfield tag="007">cr nn 008mamaa</controlfield>
  <controlfield tag="008">240720s2024    sz |    s    |||| 0|eng d</controlfield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9783031658273</subfield>
    <subfield code="9">978-3-031-65827-3</subfield>
  </datafield>
  <datafield tag="024" ind1="7" ind2=" ">
    <subfield code="a">10.1007/978-3-031-65827-3</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="050" ind1=" " ind2="4">
    <subfield code="a">RC261-271</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">MJCL</subfield>
    <subfield code="2">bicssc</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">MED062000</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">MJCL</subfield>
    <subfield code="2">thema</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
    <subfield code="a">Breast Cancer Treatment: An Interdisciplinary Approach</subfield>
    <subfield code="h">[electronic resource] /</subfield>
    <subfield code="c">edited by Nima Rezaei.</subfield>
  </datafield>
  <datafield tag="250" ind1=" " ind2=" ">
    <subfield code="a">1st ed. 2024.</subfield>
  </datafield>
  <datafield tag="264" ind1=" " ind2="1">
    <subfield code="a">Cham :</subfield>
    <subfield code="b">Springer Nature Switzerland :</subfield>
    <subfield code="b">Imprint: Springer,</subfield>
    <subfield code="c">2024.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">XI, 448 p. 54 illus., 50 illus. in color.</subfield>
    <subfield code="b">online resource.</subfield>
  </datafield>
  <datafield tag="336" ind1=" " ind2=" ">
    <subfield code="a">text</subfield>
    <subfield code="b">txt</subfield>
    <subfield code="2">rdacontent</subfield>
  </datafield>
  <datafield tag="337" ind1=" " ind2=" ">
    <subfield code="a">computer</subfield>
    <subfield code="b">c</subfield>
    <subfield code="2">rdamedia</subfield>
  </datafield>
  <datafield tag="338" ind1=" " ind2=" ">
    <subfield code="a">online resource</subfield>
    <subfield code="b">cr</subfield>
    <subfield code="2">rdacarrier</subfield>
  </datafield>
  <datafield tag="347" ind1=" " ind2=" ">
    <subfield code="a">text file</subfield>
    <subfield code="b">PDF</subfield>
    <subfield code="2">rda</subfield>
  </datafield>
  <datafield tag="490" ind1="1" ind2=" ">
    <subfield code="a">Interdisciplinary Cancer Research,</subfield>
    <subfield code="x">2731-457X ;</subfield>
    <subfield code="v">7</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Signal Transducer and Activator of Transcription as a Potential Therapeutic Target in Breast Cancer -- Triple-Negative Breast Cancer Therapy: Recent Advances, Challenges, and Future Perspective -- Advances in Local Ablative Techniques for Breast Cancer -- Radiotherapy in Breast Cancer -- Percutaneous Breast Cancer Treatment -- Revolutionizing Breast Cancer Care: Cutting-Edge Breakthroughs and Future Frontiers in Precision Medicine -- Updates on the Management of Ductal Carcinoma In Situ of the Breasts -- Nanostructured Lipid Carrier as a Strategy for the Treatment of Breast Cancer -- Managing Breast Cancer Using the Cell-Surface GRP78 -- A Hormone Immunotherapy (HIT) Combination in Advanced Breast Cancer -- Discovering New Targets in Triple-Negative Breast Cancer (TNBC): The Androgen Receptor and the Estrogen Receptor b -- Growth Factor Receptor Implications in Breast Cancer: Prospects for Their Molecular Transactivation in the Future and Obstacles for Target Therapy -- Addressing ESR1 Mutation: A Key Factor in Hormone Therapy Resistance in Breast Cancer -- Tumor Microenvironment Modulation and Its Impact on Immunotherapy in Triple-Negative Breast Cancer -- Claudin 1: An Emerging Target for Triple-Negative Breast Cancer -- Histaminergic System as a Promising Target for Breast Cancer Treatment -- Nutrient Transporters: New Molecular Targets for Triple Negative Breast Cancer in Type 2 Diabetics -- Holistic Nursing Approach: A Case Study on Integrating Traditional Chinese Medicine into Nursing Care for a Patient with Upper Limb Lymphedema and Coexisting Pressure Injury Post-breast Cancer Surgery.</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">There are different types of treatment for breast cancer, including surgery, chemotherapy, radiotherapy, hormone therapy, immunotherapy, and targeted therapy. Deciding on the types of treatment depends on several factors, such as the stage and grade of cancer, biomarkers, and general health of patients. The seventh volume of the &#x201C;Interdisciplinary Cancer Research&#x201D; series, entitled &#x201C;Breast Cancer Treatment: An Interdisciplinary Approach&#x201D; publishes comprehensive reviews on different treatment opportunities on breast cancer. An update on treatment of triple-negative breast cancer and ductal carcinoma in situ is provided. Ablative breast cancer surgery, radiotherapy, and percutaneous breast cancer treatment are explained. Promising hormone immunotherapy combination as well as targeted therapies for breast cancer is also discussed. This interdisciplinary series is of special value to researchers working on oncology. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value to researchers and oncologists who wish to extend their knowledge on breast cancer treatment.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Cancer.</subfield>
    <subfield code="9">4311</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Cancer</subfield>
    <subfield code="x">Treatment.</subfield>
    <subfield code="9">63722</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Nanomedicine.</subfield>
    <subfield code="9">64703</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Tumors</subfield>
    <subfield code="x">Immunological aspects.</subfield>
    <subfield code="9">73413</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Immunology.</subfield>
    <subfield code="9">69214</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Oncology.</subfield>
    <subfield code="9">70760</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="4">
    <subfield code="a">Cancer Biology.</subfield>
    <subfield code="9">67829</subfield>
  </datafield>
  <datafield tag="650" ind1="2" ind2="4">
    <subfield code="a">Cancer Therapy.</subfield>
    <subfield code="9">73414</subfield>
  </datafield>
  <datafield tag="650" ind1="2" ind2="4">
    <subfield code="a">Cancer Nanotechnology.</subfield>
    <subfield code="9">78154</subfield>
  </datafield>
  <datafield tag="650" ind1="2" ind2="4">
    <subfield code="a">Tumour Immunology.</subfield>
    <subfield code="9">73415</subfield>
  </datafield>
  <datafield tag="650" ind1="2" ind2="4">
    <subfield code="a">Applied Immunology.</subfield>
    <subfield code="9">80172</subfield>
  </datafield>
  <datafield tag="650" ind1="2" ind2="4">
    <subfield code="a">Oncology.</subfield>
    <subfield code="9">70760</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Rezaei, Nima.</subfield>
    <subfield code="e">editor.</subfield>
    <subfield code="0">(orcid)0000-0002-3836-1827</subfield>
    <subfield code="1">https://orcid.org/0000-0002-3836-1827</subfield>
    <subfield code="4">edt</subfield>
    <subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield>
    <subfield code="9">77538</subfield>
  </datafield>
  <datafield tag="710" ind1="2" ind2=" ">
    <subfield code="a">SpringerLink (Online service)</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
    <subfield code="t">Springer Nature eBook</subfield>
  </datafield>
  <datafield tag="776" ind1="0" ind2="8">
    <subfield code="i">Printed edition:</subfield>
    <subfield code="z">9783031658266</subfield>
  </datafield>
  <datafield tag="776" ind1="0" ind2="8">
    <subfield code="i">Printed edition:</subfield>
    <subfield code="z">9783031658280</subfield>
  </datafield>
  <datafield tag="776" ind1="0" ind2="8">
    <subfield code="i">Printed edition:</subfield>
    <subfield code="z">9783031658297</subfield>
  </datafield>
  <datafield tag="830" ind1=" " ind2="0">
    <subfield code="a">Interdisciplinary Cancer Research,</subfield>
    <subfield code="x">2731-457X ;</subfield>
    <subfield code="v">7</subfield>
    <subfield code="9">80933</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
    <subfield code="u">https://doi.org/10.1007/978-3-031-65827-3</subfield>
  </datafield>
  <datafield tag="912" ind1=" " ind2=" ">
    <subfield code="a">ZDB-2-SBL</subfield>
  </datafield>
  <datafield tag="912" ind1=" " ind2=" ">
    <subfield code="a">ZDB-2-SXB</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">61764</subfield>
    <subfield code="d">61764</subfield>
  </datafield>
</record>
